157 related articles for article (PubMed ID: 29246819)
1. Discordance between self-reported contraceptive use and detection of exogenous hormones among Malawian women enrolling in a randomized clinical trial.
Nwaohiri AN; Tang JH; Stanczyk F; Chinula L; Hurst S; Davis NL; Tegha G; Haddad L; Kourtis AP
Contraception; 2018 Apr; 97(4):354-356. PubMed ID: 29246819
[TBL] [Abstract][Full Text] [Related]
2. Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.
Pyra M; Lingappa JR; Heffron R; Erikson DW; Blue SW; Patel RC; Nanda K; Rees H; Mugo NR; Davis NL; Kourtis AP; Baeten JM;
Contraception; 2018 Apr; 97(4):357-362. PubMed ID: 29408422
[TBL] [Abstract][Full Text] [Related]
3. Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
Chinula L; Nelson JAE; Wiener J; Tang JH; Hurst S; Tegha G; Msika A; Ellington S; Hosseinipour MC; Mataya R; Haddad LB; Kourtis AP
Contraception; 2018 Sep; 98(3):193-198. PubMed ID: 29746813
[TBL] [Abstract][Full Text] [Related]
4. Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial.
Hofmeyr GJ; Singata-Madliki M; Batting J; Balakrishna Y; Morroni C
BMC Womens Health; 2024 Mar; 24(1):167. PubMed ID: 38459552
[TBL] [Abstract][Full Text] [Related]
5. Misreporting of contraceptive hormone use in clinical research participants.
Achilles SL; Mhlanga FG; Musara P; Poloyac SM; Chirenje ZM; Hillier SL
Contraception; 2018 Apr; 97(4):346-353. PubMed ID: 28966052
[TBL] [Abstract][Full Text] [Related]
6. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
Xiao B; Zeng T; Wu S; Sun H; Xiao N
Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
[TBL] [Abstract][Full Text] [Related]
7. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
[TBL] [Abstract][Full Text] [Related]
8. Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant in the ECHO Trial.
Deese J; Chen PL; Gao X; Heffron R; Hobbs M; Lapple D; Jaspan H; Miller A; Nair G; Onono M; Palanee-Phillips T; Reddy K; Steiner MJ
AIDS Behav; 2023 Mar; 27(3):978-983. PubMed ID: 36357806
[TBL] [Abstract][Full Text] [Related]
9. Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi.
Haddad LB; Tang JH; Davis NL; Kourtis AP; Chinula L; Msika A; Tegha G; Hosseinipour MC; Nelson JAE; Hobbs MM; Gajer P; Ravel J; De Paris K
mSphere; 2023 Feb; 8(1):e0058522. PubMed ID: 36622252
[TBL] [Abstract][Full Text] [Related]
10. Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
Beesham I; Bosman S; Beksinska M; Scoville CW; Smit J; Nanda K
Contraception; 2022 Apr; 108():37-43. PubMed ID: 34848180
[TBL] [Abstract][Full Text] [Related]
11. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
Abdalla KA; Shabaan MM; Stanczyk FZ
Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334
[TBL] [Abstract][Full Text] [Related]
12. Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial.
Jensen JT; Edelman A; Westhoff CL; Schreiber CA; Archer DF; Teal S; Thomas M; Brown J; Blithe DL
Contraception; 2024 Apr; ():110475. PubMed ID: 38670302
[TBL] [Abstract][Full Text] [Related]
13. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
[TBL] [Abstract][Full Text] [Related]
14. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
Kuhnz W; Staks T; Jütting G
Contraception; 1994 Dec; 50(6):563-79. PubMed ID: 7705098
[TBL] [Abstract][Full Text] [Related]
16. Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial.
Kourtis AP; Wiener J; Hurst S; Nelson JAE; Cottrell ML; Corbett A; Chinula L; Msika A; Haddad LB; Tang JH
J Acquir Immune Defic Syndr; 2019 Jun; 81(2):163-165. PubMed ID: 31095006
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.
Kaunitz AM; Bissonnette F; Monteiro I; Lukkari-Lax E; DeSanctis Y; Jensen J
Contraception; 2012 Nov; 86(5):452-7. PubMed ID: 22959906
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administration.
Hiroi M; Stanczyk FZ; Goebelsmann U; Brenner PF; Lumkin ME; Mishell DR
Steroids; 1975 Sep; 26(3):373-86. PubMed ID: 1198624
[TBL] [Abstract][Full Text] [Related]
19. [Serum levels of levonorgestrel during long-term use of Norplant].
Du M; Shao Q; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 1999 Jun; 34(6):363-5. PubMed ID: 11360617
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of four different contraceptive vaginal rings: steroid serum levels, luteal activity, bleeding control and lipid profiles.
Alvarez-Sanchez F; Brache V; Jackanicz T; Faundes A
Contraception; 1992 Oct; 46(4):387-98. PubMed ID: 1486777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]